4//SEC Filing
Riker Lauren Bullaro 4
Accession 0001209191-23-038030
CIK 0001396814other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:39 PM ET
Size
13.8 KB
Accession
0001209191-23-038030
Insider Transaction Report
Form 4
RIKER LAUREN
Senior Vice President, Finance
Transactions
- Award
Stock Option (Right to Buy)
2023-06-14+25,000→ 25,000 totalExercise: $38.74Exp: 2033-06-14→ Common Stock (25,000 underlying) - Sale
Common Stock
2023-06-14$37.47/sh−586$21,957→ 28,467 total - Award
Common Stock
2023-06-14+10,000→ 29,053 total - Sale
Common Stock
2023-06-14$38.52/sh−5,773$222,376→ 22,694 total - Sale
Common Stock
2023-06-14$39.01/sh−7$273→ 22,687 total
Footnotes (6)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.975 to $37.965, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 5.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.000 to $38.995, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.000 to $39.010, inclusive.
- [F6]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001545439
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:39 PM ET
- Size
- 13.8 KB